Steve Schonfeld’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,741
Closed -$271K 2635
2024
Q1
$271K Buy
+18,741
New +$310K ﹤0.01% 1691
2023
Q3
Sell
-18,100
Closed -$460K 2404
2023
Q2
$460K Sell
18,100
-5,826
-24% -$168K ﹤0.01% 1251
2023
Q1
$865K Buy
23,926
+6,515
+37% +$229K 0.01% 1004
2022
Q4
$689K Buy
+17,411
New +$724K 0.01% 1353
2021
Q3
Sell
-21,449
Closed -$3.56M 2536
2021
Q2
$3.56M Buy
+21,449
New +$3.35M 0.04% 545
2020
Q2
Sell
-4,991
Closed -$499K 1605
2020
Q1
$499K Buy
4,991
+2,875
+136% +$346K 0.03% 581
2019
Q4
$248K Buy
+2,116
New +$210K 0.01% 1069
2018
Q4
Sell
-6,100
Closed -$348K 1261
2018
Q3
$348K Buy
6,100
+1,100
+22% +$68.8K 0.02% 659
2018
Q2
$399K Sell
5,000
-15,008
-75% -$1.24M 0.02% 577
2018
Q1
$1.73M Sell
20,008
-26,547
-57% -$2.14M 0.13% 228
2017
Q4
$3.21M Buy
46,555
+42,995
+1,208% +$3.44M 0.26% 113
2017
Q3
$324K Sell
3,560
-17,346
-83% -$1.48M 0.03% 442
2017
Q2
$1.56M Buy
+20,906
New +$1.67M 0.16% 190
2017
Q1
Sell
-46,033
Closed -$3.35M 762
2016
Q4
$3.35M Buy
46,033
+43,805
+1,966% +$3.75M 0.43% 59
2016
Q3
$233K Buy
+2,228
New +$201K 0.04% 342
2016
Q2
Sell
-6,742
Closed -$380K 547
2016
Q1
$380K Buy
+6,742
New +$398K 0.16% 172

Other funds holding NVRO

Steve Schonfeld's NVRO Position: Q2 2024 in Review

Steve Schonfeld sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 18,741 shares — an estimated $271K sold.

Steve Schonfeld first reported a position in NVRO in Q1 2016 and held it in 16 quarters. The position peaked at $3.56M in Q2 2021. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Steve Schonfeld reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Steve Schonfeld sold 18,741 NEVRO CORP. shares in Q2 2024, an estimated $271K.
  • Steve Schonfeld first reported a position in NEVRO CORP. in Q1 2016 and held it in 16 quarters.
  • Steve Schonfeld's NEVRO CORP. position peaked at $3.56M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.